EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitDelphi-StudieOpen Access · CC BY-NC 4.0

An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials

Marie-Louise Zeissler, Kevin McFarthing, Karen G Raphael, Gary Rafaloff, Richard Windle, Camille B Carroll

Journal of Parkinson’s Disease · 2023

DOI: 10.3233/jpd-230109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Marie-Louise Zeissler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, University of Plymouth, Plymouth, UK. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Design of disease modification (DM) trials for Parkinson’s disease (PD) is challenging. Successful delivery requires a shared understanding of priorities and practicalities.

Objective

To seek stakeholder consensus on phase 3 trials’ overall goals and structure, inclusion criteria, outcome measures, and trial delivery and understand where perspectives differ.

Methods

An international expert panel comprising people with Parkinson’s (PwP), care partners (CP), clinical scientists, representatives from industry, funders and regulators participated in a survey-based Delphi study. Survey items were informed by a scoping review of DM trials and PwP input. Respondents scored item agreement over 3 rounds. Scores and reasoning were summarized by participant group each round until consensus, defined as≥70% of at least 3 participant groups falling within the same 3-point region of a 9-point Likert scale.

Results

92/121 individuals from 13 countries (46/69 PwP, 13/18 CP, 20/20 clinical scientists, representatives from 8/8 companies, 4/5 funders, and 1/1 regulator) completed the study. Consensus was reached on 14/31 survey items: 5/8 overall goals and structure, 1/8 Eligibility criteria, 7/13 outcome measures, and 1/2 trial delivery items. Extent of stakeholder endorsement for 428 reasons for scores was collated across items.

Conclusions

This is the first systematic multi-stakeholder consultation generating a unique repository of perspectives on pivotal aspects of DM trial design including those of PwP and CP. The panel endorsed outcomes that holistically measure PD and the importance of inclusive trials with hybrid delivery models. Areas of disagreement will inform mitigating strategies of researchers to ensure successful delivery of future trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansConsensusDelphi TechniqueResearch DesignSurveys and QuestionnairesClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

Delphi surveyParkinson’s diseaseclinical trialdisease modification

Autor:innen und Institutionen

  • Faculty of Health, University of Plymouth, Plymouth, UK.
  • Parkinson's Research Advocate, UK.
  • College of Dentistry, New York University, New York, NY, USA.
  • Parkinson's Research Advocate, USA.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.

Zitieren

APA

Zeissler, M. L., McFarthing, K., Raphael, K. G., Rafaloff, G., Windle, R., & Carroll, C. B. (2023). An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230109

Vancouver

Zeissler ML, McFarthing K, Raphael KG, Rafaloff G, Windle R, Carroll CB. An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-230109

BibTeX
@article{Zeissler2023,
  author = {Zeissler, Marie-Louise and McFarthing, Kevin and Raphael, Karen G and Rafaloff, Gary and Windle, Richard and Carroll, Camille B},
  title = {An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  doi = {10.3233/jpd-230109}
}
Kostenlos starten →